Remote monitoring helps COPD patients stay out of hospital 

YARMOUTH, Maine – Researchers have found that telehealth-supported oxygen therapy significantly reduced hospital readmissions. A systematic review and meta-analysis published in the Journal of Medical Internet Research evaluated the clinical effectiveness of remote monitoring and digital communication for home oxygen therapy in patients with COPD. The analysis included eight randomized controlled trials encompassing a total of 1,275 patients and compared telehealth support and usual care. Findings included: 

• Hospital readmissions: Researchers found that telehealth-supported oxygen therapy significantly reduced hospital readmissions. The analysis showed a moderate effect size, indicating that remote monitoring and timely intervention can prevent exacerbations requiring hospitalization. 
• Health-related quality of life: Patients receiving telehealth support reported noticeable improvements in their quality of life, reflecting better symptom management, greater confidence in self-care and enhanced overall well-being. 
• Adherence to oxygen therapy: Despite improvements in other areas, telehealth support did not significantly improve adherence to prescribed oxygen use. The lack of effect on adherence highlights the need for tailored behavioral interventions alongside telehealth tools. 

The review also evaluated the cost-effectiveness of telehealth-supported interventions. Researchers found that, although initial costs were higher due to technology and setup, these interventions showed potential for long-term savings by reducing hospital stays and associated health care expenses.